ArticleTranslational oncology2018

Efficacy and Safety of Nimotuzumab Plus Radiotherapy With or Without Cisplatin-Based Chemotherapy in an Elderly Patient Subgroup (Aged 60 and Older) With Nasopharyngeal Carcinoma.

Fangzheng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.